Clinical trial
Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole Long-acting Injection in the Spanish Clinical Practice: a Retrospective, Observational Study
NCT03130478 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Europe Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole Long-acting Injection in the Spanish Clinical Practice: a Retrospective, Observational Study
- Lead sponsor
- Otsuka Pharmaceutical Europe Ltd
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 18, 2017
- Completion date
- July 30, 2018
- Enrollment
- 119 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.